Press Release Details

Cerus to Present at the Stephens 2015 Fall Investment Conference on November 10, 2015

November, 03 2015

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, Cerus’ vice president and chief financial officer, is scheduled to present a corporate update at the Stephens 2015 Fall Investment Conference at 11:00 AM ET on Tuesday, November 10, 2015.

A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused in the field of blood safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for information about Cerus.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Source: Cerus Corporation

Cerus Investor Relations Contacts:

Stacey Leanos, 925-288-6137

Associate Director, Investor & Public Relations

ir@cerus.com

Lainie Corten, 925-288-6137

Vice President, Global Marketing & Investor Relations

ir@cerus.com

    Global Headquarters

  • 1220 Concord Avenue
  • Concord, CA US 94520
  • +1 925.288.6000

    European Headquarters

  • Stationsstraat 79-D
  • 3811 MH Amersfoort, Netherlands
  • +31 (0) 33 49 60 600